Wall Street Experts
ver. ZuMIgo(08/25)
Senti Biosciences, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -63
index |
0 |
1 |
2 |
3 |
4 |
5 |
Rok finansowy |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
2 |
4 |
3 |
0 |
Przychód Δ r/r |
0.0% |
363.5% |
481.5% |
87.1% |
-40.2% |
-100.0% |
Marża brutto |
-16987.1% |
-3949.7% |
-31.4% |
8.5% |
-104.8% |
0.0% |
EBIT (mln) |
-22 |
-25 |
-40 |
-71 |
-67 |
-61 |
EBIT Δ r/r |
0.0% |
13.4% |
63.8% |
74.6% |
-5.5% |
-8.6% |
EBIT (%) |
-25625.9% |
-6267.5% |
-1765.4% |
-1647.9% |
-2607.0% |
nan |
Koszty finansowe (mln) |
0 |
0 |
0 |
-4 |
0 |
0 |
EBITDA (mln) |
-21 |
-22 |
-37 |
-71 |
-62 |
-61 |
EBITDA(%) |
-25123.5% |
-5703.3% |
-1633.1% |
-1647.9% |
-2402.2% |
nan |
Podatek (mln) |
0 |
0 |
0 |
-12 |
10 |
0 |
Zysk Netto (mln) |
-21 |
-20 |
-55 |
-46 |
-93 |
-53 |
Zysk netto Δ r/r |
0.0% |
-5.4% |
176.5% |
-17.2% |
102.9% |
-43.2% |
Zysk netto (%) |
-24890.6% |
-5079.2% |
-2415.1% |
-1068.4% |
-3628.2% |
nan |
EPS |
-1.56 |
-0.46 |
-19.0 |
-1.75 |
-2.09 |
-11.49 |
EPS (rozwodnione) |
-1.56 |
-0.46 |
-19.0 |
-1.75 |
-2.09 |
-11.49 |
Ilośc akcji (mln) |
14 |
44 |
3 |
26 |
44 |
5 |
Ważona ilośc akcji (mln) |
14 |
44 |
3 |
26 |
44 |
5 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |